This suggests that K-ras and p53 alterations mostly coexist in pancreatic adenocarcinoma, but alterations in these genes are on independent pathways to pancreatic adenocarcinoma and are not in a common way of cumulative gene variation. Here, KRAS is linked to pancreatic adenocarcinoma.